Titan America SA Common Shares (TTAM)
15.65
+0.08 (0.51%)
NYSE · Last Trade: Dec 8th, 4:37 PM EST

Cystic-fibrosis-focused Sionna Therapeutics made its public debut this week, with an upsized public offering. Meanwhile, Titan America had a modest opening, just slightly higher than its initial pricing.
Via Talk Markets · February 9, 2025
